
Anemia, Iron Deficiency Tied to Acute Heart Failure in Pregnancy
Key Takeaways
- Severe anemia (Hb <7 g/dL) was associated with substantially increased AHF odds (aOR 5.06), and moderate anemia also increased risk, whereas mild anemia showed no significant association.
- Incorporating anemia into established risk models improved discrimination for AHF (AUC 0.78 to 0.83), with effect modification suggesting stronger relevance absent hypertensive disorders of pregnancy.
Anemia and iron deficiency are linked to higher odds of acute heart failure during pregnancy and after childbirth, according to a study.
Severe anemia was associated with roughly 5 times higher odds of acute
“Collectively, these findings suggest that iron deficiency and anemia may be a precipitating factor for AHF in pregnancy and postpartum,” wrote the researchers of the study. “The absence of an association with abnormal hemoglobin variants further strengthens this inference. Anemia present before AHF onset improved the discrimination of AHF as a risk factor over and above known risk factors.”
532 Women With AHF Compared With 1091 Controls
Researchers conducted a multicenter, unmatched, prospective case-control study at 10 hospitals in 4 Indian states between February 2019 and November 2024. Cases were 532 pregnant or postpartum women with clinically diagnosed AHF, and controls were 1091 women within 48 hours of childbirth who had no history or symptoms of heart disease. Median age was 25 years in both groups. Of the cases, 66 had peripartum cardiomyopathy (PPCM), and 30 (5.6%) died within 42 days of the end of pregnancy.
Anemia severity was classified using WHO criteria: mild (hemoglobin 10.0-10.9 grams per deciliter [g/dL]), moderate (7.0-9.9 g/dL), and severe (below 7.0 g/dL).
Severe Anemia Linked to 5-Fold Higher Odds of AHF
Compared with women without anemia at recruitment, those with severe anemia had significantly higher odds of AHF (adjusted OR [aOR], 5.06; 95% CI, 3.02-8.48; P < .001), as did those with moderate anemia (aOR, 1.52; 95% CI, 1.13-2.05; P = .006). Mild anemia was not significantly associated with AHF.
Adding anemia to established risk factors improved the model's ability to distinguish cases from controls, raising the area under the curve from 0.78 (95% CI, 0.76-0.81) to 0.83 (95% CI, 0.80-0.85; DeLong P < .001). The anemia association was significant only among women without hypertensive disorders of pregnancy (P for interaction = .009).
Low Hepcidin, High Soluble Transferrin Receptor Tied to AHF
Each 1-unit increase in soluble transferrin receptor was associated with 44% higher odds of AHF (aOR, 1.44; 95% CI, 1.31-1.57; P < .001). Women in the lowest quintile of hepcidin had more than double the odds of AHF compared with those in the highest quintile (aOR, 2.65; 95% CI, 1.69-4.14; P < .001).
Transferrin saturation was not significantly associated with AHF after adjustment, including for transfusion, and neither were hemoglobin variants (aOR, 1.10; 95% CI, 0.77-1.58; P = .60). The associations held among women with echocardiographic abnormalities and among those with PPCM, as well as after excluding women with known cardiac disease.
Authors Call for Screening Before and Early in Pregnancy
Anemia remains common worldwide. In 2019, 37% of pregnant women aged 15 to 49 years were affected, and iron deficiency is considered the most common nutritional deficiency leading to anemia, according to WHO.2
The study authors noted that anemia in pregnancy persists in India despite national supplementation programs, and they argued for screening for both iron deficiency and cardiac abnormalities before and early in pregnancy. They also called for cardio-obstetric guidelines that address conditions common in LMICs.1
Gaps in iron deficiency care extend to the broader heart failure population. Iron deficiency affects roughly half of patients with heart failure, whether or not they have anemia, and screening is inexpensive and guideline-endorsed. However, faculty at a recent American Journal of Managed Care®
The researchers acknowledged that cases and controls could not be matched by gestational age, so unmeasured confounding is possible. AHF was diagnosed on clinical criteria, natriuretic peptides were not measured because of cost, and reverse causation could not be fully ruled out, although no participant had heart failure before pregnancy. They added that further studies are needed to determine whether preventing or treating iron deficiency and anemia can reduce AHF risk.
References
- Nair M, Choudhury SS, Sundar A, et al. Anemia and iron status in pregnant and postpartum women with acute heart failure. JAMA Cardiol. Published online November 18, 2026. doi:10.1001/jamacardio.2026.4972
- Anemia. WHO. February 10, 2025. Accessed November 19, 2026.
https://www.who.int/news-room/fact-sheets/detail/anaemia - Gallagher A. Iron deficiency in heart failure is a workflow problem, faculty say. AJMC®. November 19, 2026. Accessed November 19, 2026.
https://www.ajmc.com/view/iron-deficiency-in-heart-failure-is-a-workflow-problem-faculty-say

